Erol Fikrig , M.D., associate professor of internal medicine, was a recipient of a 750,000, five-year grant from the Burroughs Wellcome Fund. yalemedicine.yale.edu/ym_f98/faculty/faculty1.html
"This opens up potential new avenues to disrupt the Borellia's life cycle and offers strategies for improving diagnosis and treatment of Lyme disease," Fikrig added. www.yalemedicalgroup.org/news/ymg_fikrig.html
[November 2004] Erol Fikrig, MD, and other researchers at Yale School of Medicine have identified a Lyme disease receptor called TROSPA that is used by disease agents to invade ticks. www.yalemedicalgroup.org/news/ymg_archive2.html